FDA Approves Gene Therapy with ISCRM Origins
July 5, 2023 | Categories: Core Faculty, Research |The FDA has approved a first-ever gene therapy for Duchenne muscular dystrophy based in part on technology developed by UW Medicine/ISCRM Researchers Read More